These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 11980867

  • 21. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K, Nakajima Y, Eto K, Ikeda MA.
    Oncogene; 2003 Oct 23; 22(48):7632-41. PubMed ID: 14576826
    [Abstract] [Full Text] [Related]

  • 22. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS.
    Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693
    [Abstract] [Full Text] [Related]

  • 23. E2F-1-induced p53-independent apoptosis in transgenic mice.
    Holmberg C, Helin K, Sehested M, Karlström O.
    Oncogene; 1998 Jul 16; 17(2):143-55. PubMed ID: 9674698
    [Abstract] [Full Text] [Related]

  • 24. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I, Murga M, Zubiaga A, Serrano M.
    Oncogene; 2002 May 02; 21(19):2939-47. PubMed ID: 12082524
    [Abstract] [Full Text] [Related]

  • 25. Apaf-1 is a transcriptional target for E2F and p53.
    Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Müller H, Helin K.
    Nat Cell Biol; 2001 Jun 02; 3(6):552-8. PubMed ID: 11389439
    [Abstract] [Full Text] [Related]

  • 26. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M.
    Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176
    [Abstract] [Full Text] [Related]

  • 27. Expression of the E2F family of transcription factors during murine development.
    Kusek JC, Greene RM, Nugent P, Pisano MM.
    Int J Dev Biol; 2000 Apr 21; 44(3):267-77. PubMed ID: 10853823
    [Abstract] [Full Text] [Related]

  • 28. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice.
    Iglesias A, Murga M, Laresgoiti U, Skoudy A, Bernales I, Fullaondo A, Moreno B, Lloreta J, Field SJ, Real FX, Zubiaga AM.
    J Clin Invest; 2004 May 21; 113(10):1398-407. PubMed ID: 15146237
    [Abstract] [Full Text] [Related]

  • 29. Differentially expressed genes in the lens of mimecan-null mice.
    Tasheva ES, Ke A, Deng Y, Jun C, Takemoto LJ, Koester A, Conrad GW.
    Mol Vis; 2004 Jun 17; 10():403-16. PubMed ID: 15215744
    [Abstract] [Full Text] [Related]

  • 30. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
    Guo Z, Yikang S, Yoshida H, Mak TW, Zacksenhaus E.
    Cancer Res; 2001 Dec 01; 61(23):8395-400. PubMed ID: 11731416
    [Abstract] [Full Text] [Related]

  • 31. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
    Jiang Z, Liang P, Leng R, Guo Z, Liu Y, Liu X, Bubnic S, Keating A, Murray D, Goss P, Zacksenhaus E.
    Dev Biol; 2000 Nov 01; 227(1):8-41. PubMed ID: 11076674
    [Abstract] [Full Text] [Related]

  • 32. The transcription factor E2F-1 in SV40 T antigen-induced cerebellar Purkinje cell degeneration.
    Athanasiou MC, Yunis W, Coleman N, Ehlenfeldt R, Clark HB, Orr HT, Feddersen RM.
    Mol Cell Neurosci; 1998 Sep 01; 12(1-2):16-28. PubMed ID: 9770337
    [Abstract] [Full Text] [Related]

  • 33. Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.
    Yoshida K, Inoue I.
    Oncogene; 2004 Aug 19; 23(37):6250-60. PubMed ID: 15195143
    [Abstract] [Full Text] [Related]

  • 34. Combinatorial gene control involving E2F and E Box family members.
    Giangrande PH, Zhu W, Rempel RE, Laakso N, Nevins JR.
    EMBO J; 2004 Mar 24; 23(6):1336-47. PubMed ID: 15014447
    [Abstract] [Full Text] [Related]

  • 35. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 36. Specificity in the activation and control of transcription factor E2F-dependent apoptosis.
    Hallstrom TC, Nevins JR.
    Proc Natl Acad Sci U S A; 2003 Sep 16; 100(19):10848-53. PubMed ID: 12954980
    [Abstract] [Full Text] [Related]

  • 37. Regulation of Geminin and Cdt1 expression by E2F transcription factors.
    Yoshida K, Inoue I.
    Oncogene; 2004 May 06; 23(21):3802-12. PubMed ID: 14990995
    [Abstract] [Full Text] [Related]

  • 38. Disruption of retinoblastoma protein family function by human papillomavirus type 16 E7 oncoprotein inhibits lens development in part through E2F-1.
    McCaffrey J, Yamasaki L, Dyson NJ, Harlow E, Griep AE.
    Mol Cell Biol; 1999 Sep 06; 19(9):6458-68. PubMed ID: 10454591
    [Abstract] [Full Text] [Related]

  • 39. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J, Yan PS, Cechvala M, Huang T, Farnham PJ.
    Oncogene; 2003 Mar 13; 22(10):1445-60. PubMed ID: 12629508
    [Abstract] [Full Text] [Related]

  • 40. ASPP1 and ASPP2 are new transcriptional targets of E2F.
    Fogal V, Kartasheva NN, Trigiante G, Llanos S, Yap D, Vousden KH, Lu X.
    Cell Death Differ; 2005 Apr 13; 12(4):369-76. PubMed ID: 15731768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.